Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Targher

Showing results (11-20 of 637) with videos related to

Pageof 64
Sort By:
Journal of Hepatology|October 20, 2006
Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver diseaseGiovanni Targher
Gut|September 29, 2016
Non-alcoholic fatty liver disease as driving force in coronary heart disease?Giovanni Targher
The Lancet. Diabetes & Endocrinology|April 25, 2022
Tirzepatide adds hepatoprotection to its armouryGiovanni Targher
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 10, 2026
The privilege of serving as editor-in-chief of Nutrition, Metabolism and Cardiovascular DiseasesGiovanni Targher
Arteriosclerosis, Thrombosis, and Vascular Biology|March 26, 2014
Risk of ischemic stroke and decreased serum bilirubin levels: is there a causal link?Giovanni Targher
Arteriosclerosis, Thrombosis, and Vascular Biology|May 20, 2011
High-sensitivity C-reactive protein, obesity, and subclinical atherosclerosis: implications of JUPITER from the MESA studyGiovanni Targher
Hepatobiliary Surgery and Nutrition|March 14, 2022
Long-term outcomes in patients with non-alcoholic fatty liver disease: further evidence that a multidisciplinary and patient-centred approach to treatment is neededGiovanni Targher
Liver International : Official Journal of the International Association for the Study of the Liver|April 26, 2019
Risk of atrial fibrillation in patients with nonalcoholic steatohepatitisGiovanni Targher
Annals of Internal Medicine|August 2, 2006
Carotid atherosclerosis and rheumatoid arthritisGiovanni Targher
Atherosclerosis|July 11, 2006
Non-alcoholic fatty liver disease as a determinant of cardiovascular diseaseGiovanni Targher
Pageof 64

Showing results (11-20 of 637) with videos related to

Sort By:
Pageof 64
Journal of Hepatology|October 20, 2006
Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver diseaseGiovanni Targher
Gut|September 29, 2016
Non-alcoholic fatty liver disease as driving force in coronary heart disease?Giovanni Targher
The Lancet. Diabetes & Endocrinology|April 25, 2022
Tirzepatide adds hepatoprotection to its armouryGiovanni Targher
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 10, 2026
The privilege of serving as editor-in-chief of Nutrition, Metabolism and Cardiovascular DiseasesGiovanni Targher
Arteriosclerosis, Thrombosis, and Vascular Biology|March 26, 2014
Risk of ischemic stroke and decreased serum bilirubin levels: is there a causal link?Giovanni Targher
Arteriosclerosis, Thrombosis, and Vascular Biology|May 20, 2011
High-sensitivity C-reactive protein, obesity, and subclinical atherosclerosis: implications of JUPITER from the MESA studyGiovanni Targher
Hepatobiliary Surgery and Nutrition|March 14, 2022
Long-term outcomes in patients with non-alcoholic fatty liver disease: further evidence that a multidisciplinary and patient-centred approach to treatment is neededGiovanni Targher
Liver International : Official Journal of the International Association for the Study of the Liver|April 26, 2019
Risk of atrial fibrillation in patients with nonalcoholic steatohepatitisGiovanni Targher
Annals of Internal Medicine|August 2, 2006
Carotid atherosclerosis and rheumatoid arthritisGiovanni Targher
Atherosclerosis|July 11, 2006
Non-alcoholic fatty liver disease as a determinant of cardiovascular diseaseGiovanni Targher
Pageof 64